Literature DB >> 23575754

Is vaginal delivery or caesarean section the safer mode of delivery in patients with adult congenital heart disease?

Victoria Asfour1, Michael O Murphy, Rizwan Attia.   

Abstract

A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: is vaginal delivery or caesarean section (CS) the safer mode of delivery in patients with adult congenital heart disease? Of the 119 studies, 13 papers represented the best evidence on the topic. Recommendations are based on 29 262 patients. Those having undergone successful corrective or palliative cardiac surgery for congenital heart disease, in addition to patients with unoperated congenital heart disease are a high-risk obstetric population. Heart disease is a leading cause of maternal mortality in the USA and the UK. Traditionally, CS was regarded as the mode of delivery of choice for high-risk patients, but growing experience in this field has now made this advice appear controversial. Patients are stratified into high- and low-risk, depending on the degree of heart failure symptoms [New York Heart Association (NYHA) class]. All studies demonstrated adverse outcomes in ACHD patients compared with normal age-matched controls. This pertained to a higher overall risk of maternal cardiac death, neonatal death, preterm birth, fetal growth restriction and longer hospital stay. On univariate regression analysis, the variables that imparted the highest risk to mother and foetus, were right ventricular failure, pulmonary regurgitation and pulmonary hypertension (P < 0.001). Induction of labour was deemed safe and was not associated with higher CS rates. There was no increase in maternal or neonatal complications in patients who were NYHA class I and II at labour. Patients who were NYHA class III and IV at labour had higher complication rates with adverse feto-maternal outcomes (P < 0.0001) and longer intensive care unit and hospital stay (Spearman's correlation 0.326, P = 0.007). The largest cohort from the USA (26 973 ACHD births) demonstrated that ventricular septal defect was associated with the highest risk of maternal death and complications (P < 0.05). The data would indicate that patients NYHA class I and II symptoms are suitable for VD. For most NYHA III and IV patients a trail of labour is safe with expedited delivery under good analgesic control as dictated by obstetric needs. Due to high complication risks, CS may be indicated in a proportion of patients.

Entities:  

Mesh:

Year:  2013        PMID: 23575754      PMCID: PMC3686383          DOI: 10.1093/icvts/ivt110

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  14 in total

1.  Prospective multicenter study of pregnancy outcomes in women with heart disease.

Authors:  S C Siu; M Sermer; J M Colman; A N Alvarez; L A Mercier; B C Morton; C M Kells; M L Bergin; M C Kiess; F Marcotte; D A Taylor; E P Gordon; J C Spears; J W Tam; K S Amankwah; J F Smallhorn; D Farine; S Sorensen
Journal:  Circulation       Date:  2001-07-31       Impact factor: 29.690

2.  Towards evidence-based medicine in cardiothoracic surgery: best BETS.

Authors:  Joel Dunning; Brian Prendergast; Kevin Mackway-Jones
Journal:  Interact Cardiovasc Thorac Surg       Date:  2003-12

3.  Anesthetic management of a consecutive cohort of women with heart disease for labor and delivery.

Authors:  E Goldszmidt; A Macarthur; C Silversides; J Colman; M Sermer; S Siu
Journal:  Int J Obstet Anesth       Date:  2010-03-02       Impact factor: 2.603

4.  Pregnancy complicated by maternal heart disease. A review of 519 women.

Authors:  P B McFaul; J C Dornan; H Lamki; D Boyle
Journal:  Br J Obstet Gynaecol       Date:  1988-09

5.  A retrospective survey of adverse maternal and neonatal outcomes for parturients with congenital heart disease.

Authors:  G Hidano; S Uezono; K Terui
Journal:  Int J Obstet Anesth       Date:  2011-06-08       Impact factor: 2.603

6.  Effect of maternal congenital heart defects on labor and delivery outcome: a population-based study.

Authors:  Rakefet Sidlik; Eyal Sheiner; Amalia Levy; Arnon Wiznitzer
Journal:  J Matern Fetal Neonatal Med       Date:  2007-03

7.  Anaesthesia in parturients with heart disease: a five year review in an Australian tertiary hospital.

Authors:  R K Boyle
Journal:  Int J Obstet Anesth       Date:  2003-07       Impact factor: 2.603

8.  Foetomaternal outcome of pregnancy with cardiac disease.

Authors:  Tayyiba Wasim; Wasim Amer; Ashraf Majrroh; Saqib Siddiq
Journal:  J Pak Med Assoc       Date:  2008-04       Impact factor: 0.781

9.  [Perinatal outcomes of 45 pregnant women with pulmonary hypertension complicating congenital heart disease].

Authors:  Yuan Meng; Yin-Ping Huang; Xiao-Li Liu; Yan-Jun Huang; Jie Zhou; Chun-Qiu Xiong; Li-Qun Wu; Bo Wang; Cai-Ping Cai
Journal:  Zhonghua Fu Chan Ke Za Zhi       Date:  2007-10

10.  Obstetric outcomes in pregnant women with congenital heart disease.

Authors:  David W Ouyang; Paul Khairy; Susan M Fernandes; Michael J Landzberg; Katherine E Economy
Journal:  Int J Cardiol       Date:  2009-05-02       Impact factor: 4.164

View more
  5 in total

1.  Reversible pulmonary hypertension and high-output heart failure triggered by pregnancy in a patient with congenital arteriovenous malformation: A case report.

Authors:  Héctor Saavedra; Celina Toncel; Vanessa Delgado; Orlando Borré; José Rojas-Suárez
Journal:  Obstet Med       Date:  2018-05-22

Review 2.  Role of echocardiography in the management of cardiac disease in women.

Authors:  Wan Joo Shim
Journal:  J Cardiovasc Ultrasound       Date:  2014-12-26

3.  Anesthetic Implications for Cesarean Section in a Parturient with Complex Congenital Cyanotic Heart Disease.

Authors:  Huili Lim; Chuen Jye Yeoh; Jerry Tan; Harikrishnan Kothandan; May U S Mok
Journal:  Case Rep Anesthesiol       Date:  2018-03-29

Review 4.  Pulmonary Hypertension in Pregnancy: Challenges and Solutions.

Authors:  Hesham Afify; Alexander Kong; Jopher Bernal; Islam Y Elgendy
Journal:  Integr Blood Press Control       Date:  2022-04-02

5.  Pregnancy outcomes in patients with pulmonary arterial hypertension: A retrospective study.

Authors:  Jun Luo; Huafang Shi; Li Xu; Wei Su; Jiang Li
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.